STAT+: Exclusive: Mystery man gets experimental GLP-1
Why this matters: health reporting relevant to everyday decisions and well-being.
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.&#x A0;Sign up here&#x A0;to receive it in your inbox on Tuesdays and Thursdays. Let’s jump right in with Lizzy’s super interesting scoop about the one-and-only person granted compassionate-use access to an experimental GLP-1. Send news tips and best guesses to John.Wilkerson@statnews.com or John_Wilkerson.07 on Signal. Why did one man get special access to an experimental GLP-1? Here’s what we know about the sole person granted special access to Eli Lilly’s experimental obesity drug, thanks to Lizzy Lawrence’s reporting.Continue to STAT+ to read the full story…